There are no known clinically significant drug interactions, but the effect of r-HuEPO may be restored by the simultaneous therapeutic administration of a hematinic agent eg, ferrous sulfate when a deficiency state exists.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education